- Home
- ONCY vs FNGR Comparison
ONCY vs FNGR Comparison
Compare ONCY & FNGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- FNGR
- Stock Information
- Founded
- ONCY 1998
- FNGR 2016
- Country
- ONCY Canada
- FNGR Singapore
- Employees
- ONCY N/A
- FNGR N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- FNGR Computer Software: Prepackaged Software
- Sector
- ONCY Health Care
- FNGR Technology
- Exchange
- ONCY Nasdaq
- FNGR Nasdaq
- Market Cap
- ONCY 89.7M
- FNGR 96.2M
- IPO Year
- ONCY 1999
- FNGR N/A
- Fundamental
- Price
- ONCY $1.11
- FNGR $1.51
- Analyst Decision
- ONCY Strong Buy
- FNGR
- Analyst Count
- ONCY 5
- FNGR 0
- Target Price
- ONCY $5.00
- FNGR N/A
- AVG Volume (30 Days)
- ONCY 900.3K
- FNGR 386.7K
- Earning Date
- ONCY 11-07-2025
- FNGR 10-14-2025
- Dividend Yield
- ONCY N/A
- FNGR N/A
- EPS Growth
- ONCY N/A
- FNGR N/A
- EPS
- ONCY N/A
- FNGR N/A
- Revenue
- ONCY N/A
- FNGR $35,881,122.00
- Revenue This Year
- ONCY N/A
- FNGR N/A
- Revenue Next Year
- ONCY N/A
- FNGR N/A
- P/E Ratio
- ONCY N/A
- FNGR N/A
- Revenue Growth
- ONCY N/A
- FNGR 15.09
- 52 Week Low
- ONCY $0.33
- FNGR $1.03
- 52 Week High
- ONCY $1.51
- FNGR $5.20
- Technical
- Relative Strength Index (RSI)
- ONCY 39.70
- FNGR 44.90
- Support Level
- ONCY $1.16
- FNGR $1.51
- Resistance Level
- ONCY $1.32
- FNGR $1.70
- Average True Range (ATR)
- ONCY 0.07
- FNGR 0.11
- MACD
- ONCY -0.01
- FNGR -0.01
- Stochastic Oscillator
- ONCY 10.42
- FNGR 21.05
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
About FNGR FingerMotion Inc.
FingerMotion Inc is engaged in the provision of mobile payment and recharge services in the Chinese market. The company business line includes Telecommunications Products and Services; Value Added Products and Services; Short Message Services (SMS) and Multimedia Messaging Services (MMS); a Rich Communication Services (RCS) platform; Big Data Insights; and a Video Games Division (inactive). It principally earns revenue by providing mobile payment and recharge services to customers of telecommunications companies in China.